Protección del inicio de la vida humana. Una reflexión ética desde la perspectiva científica
DOI:
https://doi.org/10.11565/arsmed.v33i1.250Resumen
Sin resumen disponibleCitas
Ver C. A. Bedate, Cefalo, R.C., ‘The Zygote: To Be or not Be a Person,’ Journal of Medicine and Philosophy 14 (1989): 641-645.
Ver A. J. Wilcox, ‘Incidence of Early Loss of Pregnancy,’ New England Journal of Medicine, 319 (1988): 189-194.
J. C. Cross, Z. Werb, and S. J. Fisher, ‘Implantation and the Placenta: Key Pieces of the Development Puzzle,’ Science, 266 (1994): 1508-1518, pág. 1514-1516.
Ver S. Tabibzadeh, A. Babaknia, ‘The Signals and Molecular Pathways Involved in Implantation, a Symbiotic Interaction between Blastocyst and Endometrium Involving Adhesion and Tissue Invasion’, Human Reproduction 10 (1995): 1579-1602; J. C. Cross, Z. Werb, and S. J. Fisher, ‘Implantation and the Placenta: Key Pieces of the Development Puzzle,’ Science, 266 (1994): 1508- 1518, pág. 1510-1513; B. A. Lessey, ‘The Role of the Endometrium During Embryo Implantation’, Human Reproduction Suppl. 6 (2000): 39-50.
Ver A. M. Sharkey, K. Dellow, M. Blayney, M. Macnamee, S. Charnock-Jones, S. K. Smth, ‘Stage-Specific Expression of Cytokine and Receptor Messenger Ribonucleic Acids in Human Preimplantation Embryos’, Biological Reproduction 53 (1995): 974-981.
Ver C. Hansis, J. A. Grifo, L. C. Krey, ‘Oct-4 Expression in Inner Cell Mass and Trophoectoderm of Human Blastocysts’, Molecular Human Reproduction 6 (2000): 999-1004.
Ver J. Adjaye, R. Daniels, M. Monk, ‘The Construction of cDNA Libraries from Human Single Preimplantation Embryos and their Use in the Study of Gene Expression during Development’, Journal of Assisted Reproduction Genetics 15 (1998): 344-348; R. Daniels, S. Lowell, V. Bolton, M. Monk, ‘Transcription of Tissue-Specific Genes in Human Preimplantation Embryos’, Human Reproduction 12 (1997): 2251-2256.
Ver A. Ao, R. P. Erickson, R. M. Winston, A. H. Handyside, ‘Transcription of Paternal YLinked Genes in the Human Zygote as Early as the Pronucleate Stage’, Zygote 2 (1994): 281-287.
Ver A. E. H. Emery, Elements of Medical Genetics (New York: Churchill Livingstone, 1983), pág. 103.
Ver J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro, M. A. Walknitz, J. J. Swiergiel, V. S. Marshall, J. M. Jones, ‘Embryonic Stem Cell Lines Derived from Human Blastocysts’. Science 282 (1998): 1145-1147.
M. J. Shamblott, J. Axelman, S. Wang, E. M. Bugg, J. W. Littlefield, P. J. Donovan, P. D. Blumenthal, G. R. Huggins, J. D. Geathart, ‘Derivation of Pluripotent Stem Cells from Cultured Human Primordial Germ Cells’. Proceedings National Academy of Science USA 95 (1998): 1372613731.
Ver W. Y. Chen, T. M. Townes, ‘Molecular Mechanism for Silencing Virally Transduced Genes Involves Histone Deacetylation and Chromatin Condensation’. Proceedings National Academy of Science USA 97 (2000): 377-382.
Ver L. Armstrong, M. Lako, J. Lincoln, P. M. Calms, N. Hole, ‘MTert Expression Correlates with Telomerase Activity During the Differentiation of Murine Embryonic Stem Cells’. Mechanisms Development 97 (2000): 109-116; y M. C. Yoder, K. Hiatt, ‘Murine Yolk Sac and Bone Marrow Hematopoietic Cells with High Proliferative Potential Display Different Capacities for Producing Colony-forming Cells ex Vivo’. Journal of Hematology Stem Cell Research 8 (1999): 421-430.
Ver M. Amit, M. K. Carpenter, M. S. Inokuma, C. P. Chiu, C. P. Harris, M. A. Waknitz, J. Itskovitz-Eldor, J. A. Thomson, ‘Clonally Derived Human Embryonic Stem Cells Lines Maintain Pluripotency and Proliferative Potential for Prolonged Periods of Culture’. Developmental Biology 227 (2000): 271-278.
Ver A. Luther-Wyrsch, E. Costello, M. Thali, E. Buetti, C. Nissen, D. Surbek, W. Holzgreve, A. Gratwohi, A. Tichell, A. Wodnar Fillpowicz, ‘Stable Transduction with Lenti-viral Vectors and Amplification of Immature Hematopoietic Progenitors from Cord Blood of Preterm Human
Fetuses’. Human Gene Therapy 12 (2001): 377-389; y L. E. Shields, H. P. Klem, R. G. Andrews, ‘Highly Efficient Gene Transfer into Preterm CD34+ Hematopoietic Progenitor Cells’. American Journal Obstetrics Ginecology 183 (2000): 732-737.
Asíhan especulado J. Geathart, ‘New Potential for Human Embryonic Stem Cells. Science 282 (1998): 1061-1062; y P. D. Rathjen, J. Lake, L.M. Whyatt, M. D. .Bettess, J. Rathjen, ‘Properties and Uses of Embryonic Stem Cells: Prospects for Application to Human Biology and Gene Therapy’. Reproductive Fertility Development 10 (1998): 31-47.
Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J., Campbell, K.H., ‘Viable Offspring Derived from Fetal and Adult Mammalian Cells’, Nature 385 (1997): 810-813.
Ver P. G. Shiels, A. J. Kind, K. H. S. Campbell. D. Waddington, I. Wilmut, A. Colman, A. E. Schnieke, ‘Analysis of Telomere Lenghts in Cloned Sheep’. Nature 399 (1999): 316-317. 19 R. Jaenisch and I. Wilmut, ‘Don´t Clone Humans!’, Science 291 (2001): 2552.
Hwang, W.S., Ryu, Y.J., Park, J.H., Lee, E.G., Koo, J.M., Chun, H.Y., Le, B.C., Kang, S.J., Ahn, C., Hwang, J.H., Park, K.Y., Cibelli, J.B., Moon, S.Y., ‘Evidence of a Pluripotent Human Embryonic Stem Cell Line Derived from a Cloned Blastocyst’, Science (2004, February 12).
Ver A. Glasier, ‘Emergency Postcoital Contraception’, The New England Journal of Medicine 337 (1997): 1058.
Decreto 873 Ministerio de Relaciones Exteriores (1991).
The Allan Guttmacher Institute (1999), Chart 6.1, pág. 42-43.
F. Galton, Inquiries into Human Faculty and its Development (London: J. M. Dent and Sons, 1913), pág. 17.
Ver A. Lippman, ‘Prenatal Gene Screening and Testing’, American Journal of Law and Medicine 17 (1991): 16-19.
Ver C. Dunne, C. Waren, ‘Lethal Autonomy: the Malfunction of the Informed Consent Mechanism within the Context of Prenatal Diagnosis of Genetic Variants’, Issues in Law and Medicine 14 (1998): 165-202. Y A. Asch, ‘Prenatal Diagnosis and Selective Abortion: a Challenge to Practice and Policy’, Journal of Public Health 89 (1999): 1649-1657.
Ver D. Butler, ‘Ethics Treaty to Target Genome Implications’, Nature 371 (1994): 369.
Ver N. Y. Press, C. H. Browner, ‘Risk, Autonomy and Responsibility. Informed Consent for Prenatal Testing’, Hustings Center Report 25 (1995): S9-S12.
Ver K. L. Garver, B. Garver, ‘The Human Genome Project and Eugenic Concerns’, American Journal of Human Genetics 54 (1994): 148-158, pág. 153.
A. Clarke, ‘Genetic, Ethics and Audit’, Lancet 335 (1990): 1145-1147.
Ver M. Borrow, ‘Redrafted Chinese Law Remains Eugenic’, Journal of Medical Genetics 32 (1995): 409.
Academia Pontificia para la Vida (Comunicado 24-8-2000).
Ver por ejemplo: Lovell, M.J., ‘The Role of Stem Cells for Treatment of Cardiovascular Disease’, Cell Proliferation 37 (2004): 67-87; Mollura, D.J., Hare, J.M., Rabb, H., ‘Stem-cell Therapy for Renal Diseases’, American Journal of Kidney Diseases 42 (2003): 891-905; Bartley, J., Carroll, J.E., ‘Stem Cell Therapy for Cerebral Palsy’, Expert Opinion Biological Therapy 3 (2003): 541- 549; Suárez, R.F., ‘Adult Neurogenesis and Stem Cells. Functional Capacity’, Annual Review Aca211 Protección del inicio de la vida humana.
demia Nacional de Medicina (Madrid) 119 (2002): 507-521; Ostenfeld, T., Svendsen, C.N., ‘Recent Advances in Sten Cell Neurobiology’, Advanced Technical Standard Neurosurgery 28 (2003): 3-89.
Long, G.D., Laughlin, M., Madan, B., Kurtzberg, J., Gasparetto, C., Morris, A., Rizzieri, D., Smith C., Vredenburgh, J., Halperin, E.C., Broadwater, G., Niedzwiecki, D., Chao, N.J., ‘ Unrelated Umbilical Cord Blood Transplantation in Adult Patients’, Biological Blood Marrow Transplantation 9 (2003): 772-780.
Academia Pontificia para la Vida (Comunicado 31-10-2000).
Donum Vitae, Instrucción sobre el Respeto de la Vida Humana en sus Orígenes y Sobre la Dignidad de la Procreación, Sagrada Congregación de la Fe, 1,2. Y Evangelium Vitae, Juan Pablo II.
Ver E. R. Hepburn, ‘Genetic Testing and Early Diagnosis and Intervention: Boom or Burden?’, Journal of Medical Ethics 22 (1996): 105-110.
Descargas
Publicado
Número
Sección
Categorías
Licencia
Derechos de autor 2016 ARS MEDICA Revista de Ciencias Médicas
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
A partir del 1 de octubre 2023, los autores/as conservan sus derechos de autor y garantizan a la revista el derecho de primera publicación de su obra, la que estará simultáneamente sujeta a la Licencia CC BY-SA 4.0 (Ver declaración de Acceso Abierto).
